Notably, treatment with pyridoxamine in the DM + ALI + PYR group significantly reduced the levels of WBC, IL-6, and TNF-α compared to the DM + ALI group (Fig. 5A-C). The gene discussed is IL6; the disease is acute respiratory distress syndrome.